Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Leili Rahimi MD

Leili Rahimi MD

Internal Medicine Resident, Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, Ohio

Dr. Leili Rahimi is an Internal Medicine resident at Case Western Reserve University and University Hospitals Cleveland Medical Center. Her research focuses on type 2 diabetes, metabolic syndrome, and fatty liver disease. She has recently published an article on effects of SGLT2i on nonalcoholic fatty liver disease and another article on insulin-glucose metabolism in advanced renal disease.

Disclosures

Dr. Rahimi has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Dapagliflozin Plus Saxagliptin Add-On to Metformin Reduces Liver Fat and Adipose Tissue Volume

Most Read This Week

Recently Updated